ZOOM ON Video – YUMAB
YUMAB is an innovative biotech company developing next-generation therapeutic antibodies for clients and partners worldwide.
Their platform includes proprietary library technologies, such as fully human antibody libraries, patient-derived libraries, and immune libraries from different species.
YUMAB integrates all technologies from discovery through engineering and AI-enabled lead optimization, providing developability-approved therapeutic lead candidates.